GlaxoSmithKline, the world’s second-biggest pharmaceutical group, Monday ended a lengthy search for a new head with the appointment of its youngest chief executive – 43-year-old Briton, Andrew Witty.

VIDEO

Andrew Jack on what the appointment of Andrew Witty means for GlaxoSmithKline

Mr Witty, currently head of GSK’s European division, will take over from Jean-Pierre Garnier when he steps down in May next year in a move that signals a shift towards a more youthful and internationally oriented management